Nanoparticles and Their Influence on Organs through the Gut–Organ Axis: Innovations in Drug Delivery and Gut Microbiota Metabolites

Dear Colleagues,

We are pleased to invite you to explore the specialized realm of nanoscale particles and their profound influence on organs through the intricate gut–organ axis. The unique properties and size of nanoparticles have propelled their status as promising agents for revolutionizing drug delivery techniques. This Special Issue aims to illuminate innovative paths through which nanoparticles traverse the gut–organ axis, showcasing their potential to optimize drug distribution and targeting across diverse organ systems. Additionally, it investigates the symbiotic relationship between nanoparticles and gut microbiota metabolites, revealing an intriguing interplay that holds promise for therapeutic advancements. Our objective is to delve into these dynamic interactions, unraveling novel insights and facilitating future breakthroughs in medicine and biomedical research.

This Special Issue aims to meticulously explore the transformative potential of nanoscale particles within the context of the gut–organ axis. Its objective is to elucidate the pivotal role of nanoparticles in advancing oral drug delivery techniques and comprehending the intricate interplay between nanoparticles and gut microbiota metabolites.

In this Special Issue, original research articles and reviews are welcome. Research areas include, but are not limited to, the following: investigations into nanoparticle-based drug delivery systems via oral delivery, their impact on various organ systems, and their intricate interplay with gut microbiota metabolites. We encourage contributions that deepen our understanding of these interactions, thus fostering advancements in medicine and biomedical research.

We look forward to receiving your contributions.

Dr. Yang-Bao Miao
Dr. Zhicheng Le
Prof. Dr. Sanjun Shi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.